Newsroom
Strive to Deliver Breakthroughs
Cambridge, MA, Rotterdam, NL, Shanghai, CN – March 12, 2025 - Élancé Therapeutics aims to improve current obesi...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — March 10, 2025 Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to th...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — March 10, 2025 Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to th...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN – February 25, 2025 HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company inc...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — February 20, 2025 Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceut...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN – February 13, 2025 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceu...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — February 4, 2025 Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceuti...
View moreCambridge, MA, Rotterdam, NL, Shanghai, CN — January 10, 2025 Harbour BioMed (HKEX: 02142, the “Company”), a global biophar...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN — November 14, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceuti...
View moreCambridge, MA, Rotterdam, NL, Suzhou, CN – November 8, 2024 Harbour BioMed (the "Company”; HKEX: 02142), a global biopharmaceutic...
View more